← Back to the feed

embotech AG

History from 28 Jul 2017

UID

CHE-195.606.420

Legal form

AG

Canton

ZH

Founded

not in the record

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 28 Dec 2018 · legal date 12 Dec 2018

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   127’300 → 159’760

   Shares

   127’300 → 159’760

   New shares, % of post-step shares

   20.3% (32’460 new)

   Aktienkapital neu: CHF 159'760.00 [bisher: CHF 127'300.00]. Liberierung Aktienkapital neu: CHF 159'760.00 [bisher: CHF 127'300.00]. Aktien neu: 159'760 Namenaktien zu CHF 1.00 [bisher: 127'300 Namenaktien zu CHF 1.00].

   SHAB HR02-1004531782 ↗

2. SHAB published 14 Dec 2021 · legal date 1 Dec 2021

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   159’760 → 225’059

   Shares

   159’760 → 225’059

   New shares, % of post-step shares

   29.0% (65’299 new)

   Aktienkapital neu: CHF 225'059.00 [bisher: CHF 159'760.00]. Liberierung Aktienkapital neu: CHF 225'059.00 [bisher: CHF 159'760.00]. Aktien neu: 225'059 Namenaktien zu CHF 1.00 [bisher: 159'760 Namenaktien zu CHF 1.00].

   SHAB HR02-1005356099 ↗

3. SHAB published 20 Nov 2024 · legal date 13 Nov 2024

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   225’059 → 304’731

   Shares

   225’059 → 304’731

   New shares, % of post-step shares

   26.1% (79’672 new)

   Share classes

   225’059 × CHF 1 · 79’672 × CHF 1 Vorzugsaktien B1

   Aktienkapital neu: CHF 304'731.00 [bisher: CHF 225'059.00]. Liberierung Aktienkapital neu: CHF 304'731.00 [bisher: CHF 225'059.00]. Aktien neu: 225'059 Namenaktien zu CHF 1.00 und 79'672 Namenaktien zu CHF 1.00 (Vorzugsaktien B1) [bisher: 225'059 Namenaktien zu CHF 1.00].

   SHAB HR02-1006182869 ↗

4. SHAB published 6 Dec 2024 · legal date 29 Nov 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   304’731 → 388’260

   Shares

   304’731 → 388’260

   New shares, % of post-step shares

   21.5% (83’529 new)

   Share classes

   163’422 × CHF 1 · 163’201 × CHF 1 Vorzugsaktien B1 · 61’637 × CHF 1 Vorzugsaktien B2

   Aktienkapital neu: CHF 388'260.00 [bisher: CHF 304'731.00]. Liberierung Aktienkapital neu: CHF 388'260.00 [bisher: CHF 304'731.00]. Aktien neu: 163'422 Namenaktien zu CHF 1.00, 163'201 Namenaktien zu CHF 1.00 (Vorzugsaktien B1) und 61'637 Namenaktien zu CHF 1.00 (Vorzugsaktien B2) [bisher: 225'059 Namenaktien zu CHF 1.00 und 79'672 Namenaktien zu CHF 1.00 (Vorzugsaktien B1)].

   SHAB HR02-1006196649 ↗

5. SHAB published 14 Apr 2026 · legal date 2 Apr 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   388’260 → 504’835

   Shares

   388’260 → 504’835

   New shares, % of post-step shares

   23.1% (116’575 new)

   Share classes

   161’585 × CHF 1 · 163’201 × CHF 1 Vorzugsaktien B1 · 61’637 × CHF 1 Vorzugsaktien B2 · 118’412 × CHF 1 Vorzugsaktien B-Extension

   Aktienkapital neu: CHF 504'835.00 [bisher: CHF 388'260.00]. Liberierung Aktienkapital neu: CHF 504'835.00 [bisher: CHF 388'260.00]. Aktien neu: 161'585 Namenaktien zu CHF 1.00, 163'201 Namenaktien zu CHF 1.00 (Vorzugsaktien B1), 61'637 Namenaktien zu CHF 1.00 (Vorzugsaktien B2) und 118'412 Namenaktien zu CHF 1.00 (Vorzugsaktien B-Extension) [bisher: 163'422 Namenaktien zu CHF 1.00, 61'637 Namenaktien zu CHF 1.00 (Vorzugsaktien B2) und 163'201 Namenaktien zu CHF 1.00 (Vorzugsaktien B1)].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5
   • A new class of preferred shares was created.+1.5

   Classifier score 0.93 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006623747 ↗

6. SHAB published 4 Sep 2026 · legal date 31 Aug 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   504’835 → 529’505

   Shares

   504’835 → 529’505

   New shares, % of post-step shares

   4.7% (24’670 new)

   Share classes

   161’585 × CHF 1 · 163’201 × CHF 1 Vorzugsaktien B1 · 61’637 × CHF 1 Vorzugsaktien B2 · 143’082 × CHF 1 Vorzugsaktien B-Extension

   Aktienkapital neu: CHF 529'505.00 [bisher: CHF 504'835.00]. Liberierung Aktienkapital neu: CHF 529'505.00 [bisher: CHF 504'835.00]. Aktien neu: 161'585 Namenaktien zu CHF 1.00, 163'201 Namenaktien zu CHF 1.00 (Vorzugsaktien B1), 61'637 Namenaktien zu CHF 1.00 (Vorzugsaktien B2) und 143'082 Namenaktien zu CHF 1.00 (Vorzugsaktien B-Extension) [bisher: 163'201 Namenaktien zu CHF 1.00 (Vorzugsaktien B1), 118'412 Namenaktien zu CHF 1.00 (Vorzugsaktien B-Extension), 61'637 Namenaktien zu CHF 1.00 (Vorzugsaktien B2) und 161'585 Namenaktien zu CHF 1.00].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006747694 ↗

Published by 6 Sep 2026

Latest available record · 8 Oct 2026